Veracyte is a genomic diagnostics company. It is engaged in the development of molecular tests that leverage innovations in genomic technology and machine learning to enable diagnostic, prognostic, and treatment decisions in diseases such as thyroid cancer, lung cancer, breast cancer, and idiopathic pulmonary fibrosis.
|HQ||South San Francisco, CA, US||Map|
Net income (Q3, 2020)
EBIT (Q3, 2020)
Market capitalization (19-Jan-2021)
Closing stock price (19-Jan-2021)
|USD||Q1, 2018||Q2, 2018||Q3, 2018||Q1, 2019||Q2, 2019||Q3, 2019||Q1, 2020||Q2, 2020||Q3, 2020|
Depreciation and Amortization
|Company Name||Date||Deal Size|
|Allegro Diagnostics||September 04, 2014||$21 m|
|Veracyte International Corp.|
Veracyte revenue breakdown by business segment: 89.2% from Testing Revenue, 6.7% from Biopharmaceutical Revenue and 4.1% from Other
Veracyte has 830 Twitter Followers. The number of followers has increased 2.1% month over month and increased 3.1% quarter over quarter
Tweets last 30 days
Avg. likes per Tweet
Tweets with engagement
When was Veracyte founded?
Veracyte was founded in 2008.
Who are Veracyte key executives?
Veracyte's key executives are Bonnie H. Anderson, Keith Kennedy and Giulia C. Kennedy.
How many employees does Veracyte have?
Veracyte has 354 employees.
What is Veracyte revenue?
Latest Veracyte annual revenue is $120.4 m.
What is Veracyte revenue per employee?
Latest Veracyte revenue per employee is $340 k.
Who are Veracyte competitors?
Competitors of Veracyte include Biodesix, Roka Bioscience and ID Genomics.
Where is Veracyte headquarters?
Veracyte headquarters is located at 6000 Shoreline Ct #300, South San Francisco.
Where are Veracyte offices?
Veracyte has offices in South San Francisco and Austin.
How many offices does Veracyte have?
Veracyte has 2 offices.
Receive alerts for 300+ data fields across thousands of companies